Explore 3 Stock Ideas & Industry Insights Download Free Report

Zero Candida Technologies Inc.

Company price
0.14 CAD 0.00(0%)
Last update at 2026-11-03T14:30:00Z
Market Cap
3.71M

Momentum Score

…

Zero Candida Technologies, Inc., a technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis. It offers Zero Candida, a smart vaginal diagnostic device that collects and transmits treatment data to the attending physician in real time for assessment, treatment, personalization, and monitoring. The company is headquartered in Vancouver, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.14
Low
0.14
High
52 Week Price Range
0.11
Low
0.36
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Zero Candida Technologies Inc. is a publicly listed company on the TSX Venture Exchange (ZCT); public disclosures provide limited detail on its operations and product portfolio. Long-term growth will depend on clarifying strategy, executing initiatives, securing financing and achieving market adoption; investors may find potential upside if management delivers verifiable milestones.

Key risks include limited disclosure, execution and financing risk, low liquidity and regulatory or clinical hurdles if the company operates in health-related markets.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.14
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
-
ROE
-
Net Debt
0.00M
ROCE
-94.56%
Diluted EPS TTM
-0.29

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31
Type yearly yearly
Date 2024-12-31 2023-12-31
Income before tax -6.28M -0.01M
Net income -6.28M -0.01M
Selling general administrative 0.96M 0.01M
Operating income -2.24M -0.01M
Interest expense 0.14M -
Interest income 0.10M -
Net interest income -0.04M -
Total revenue 0.00M 0.00M
Total operating expenses 2.24M 0.01M
Total other income expense net -4.00M -
Net income from continuing ops -6.28M -0.01M
Breakdown 2024-12-31 2023-12-31
Type yearly yearly
Date 2024-12-31 2023-12-31
Total assets 3.21M 0.00M
Total liab 0.87M 0.03M
Total stockholder equity 2.34M -0.02M
Capital stock 0.20M 0.04M
Retained earnings -10.48M -0.06M
Cash 0.24M 0.00M
Total current liabilities 0.84M 0.03M
Net debt 0.00M 0.00M
Short long term debt 0.01M 0.01M
Total current assets 3.19M 0.00M
Short term investments 2.81M -
Accounts payable 0.00M -
Non current assets total 0.03M 0.00M
Capital lease obligations 0.03M -
Breakdown 2024-12-31 2023-12-31
Type yearly yearly
Date 2024-12-31 2023-12-31
Investments -1.35M -
Net borrowings 0.00M -
Total cash from financing activities 2.55M -
Net income -6.28M -0.01M
Change in cash 0.27M -0.01M
Begin period cash flow 0.17M 0.01M
End period cash flow 0.24M 0.00M
Total cash from operating activities -0.94M -0.01M
Issuance of capital stock 2.55M -
Capital expenditures 0.00M 0.00M
Change in working capital 0.01M 0.01M
Other non cash items 5.34M -
Free cash flow -0.94M -0.01M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
ZCT
Zero Candida Technologies Inc.
-
-%
0.14 - - - 2.27
TLT
Theralase Technologies Inc.
0.01
5.56%
0.19 - - 90.07 82.51
CNVI
Conavi Medical Corp.
0.01
4.55%
0.12 - - 66.65 -
PINK
Perimeter Medical Imaging AI Inc
-0.01
5.56%
0.17 4.13 - 18.78 11.34
CHER
Cheelcare Inc.
-
-%
1.25 - - 20.92 106.42

Profile*

Zero Candida Technologies Inc.

Zero Candida Technologies, Inc., a technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis. It offers Zero Candida, a smart vaginal diagnostic device that collects and transmits treatment data to the attending physician in real time for assessment, treatment, personalization, and monitoring. The company is headquartered in Vancouver, Canada.

666 Burrard Street, Vancouver, BC, Canada, V6C 3P6

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…